Literature DB >> 33675164

Can we predict which COVID-19 patients will need transfer to intensive care within 24 hours of floor admission?

Alfred Z Wang1, Robert Ehrman2, Antonino Bucca1, Alexander Croft1, Nancy Glober1, Daniel Holt1, Thomas Lardaro1, Paul Musey1, Kelli Peterson1, Jason Schaffer1, Russell Trigonis1, Benton R Hunter1.   

Abstract

BACKGROUND: Patients with COVID-19 can present to the emergency department (ED) at any point during the spectrum of illness, making it difficult to predict what level of care the patient will ultimately require. Admission to a ward bed, which is subsequently upgraded within hours to an intensive care unit (ICU) bed, represents an inability to appropriately predict the patient's course of illness. Predicting which patients will require ICU care within 24 hours would allow admissions to be managed more appropriately.
METHODS: This was a retrospective study of adults admitted to a large health care system, including 14 hospitals across the state of Indiana. Included patients were aged ≥ 18 years, were admitted to the hospital from the ED, and had a positive polymerase chain reaction (PCR) test for COVID-19. Patients directly admitted to the ICU or in whom the PCR test was obtained > 3 days after hospital admission were excluded. Extracted data points included demographics, comorbidities, ED vital signs, laboratory values, chest imaging results, and level of care on admission. The primary outcome was a combination of either death or transfer to ICU within 24 hours of admission to the hospital. Data analysis was performed by logistic regression modeling to determine a multivariable model of variables that could predict the primary outcome.
RESULTS: Of the 542 included patients, 46 (10%) required transfer to ICU within 24 hours of admission. The final composite model, adjusted for age and admission location, included history of heart failure and initial oxygen saturation of <93% plus either white blood cell count > 6.4 or glomerular filtration rate < 46. The odds ratio (OR) for decompensation within 24 hours was 5.17 (95% confidence interval [CI] = 2.17 to 12.31) when all criteria were present. For patients without the above criteria, the OR for ICU transfer was 0.20 (95% CI = 0.09 to 0.45).
CONCLUSIONS: Although our model did not perform well enough to stand alone as a decision guide, it highlights certain clinical features that are associated with increased risk of decompensation.
© 2021 by the Society for Academic Emergency Medicine.

Entities:  

Keywords:  COVID-19; critical care; emergency medicine

Year:  2021        PMID: 33675164     DOI: 10.1111/acem.14245

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  8 in total

1.  Factors which impact the length of hospitalisation and death rate of COVID-19 patients based on initial triage using capillary blood gas tests: a single centre study.

Authors:  Tomasz Ilczak; Alicja Micor; Wioletta Waksmańska; Rafał Bobiński; Marek Kawecki
Journal:  Sci Rep       Date:  2022-10-19       Impact factor: 4.996

2.  Re: Can we predict which COVID-19 patients will need transfer to the intensive care within 24 hours of floor admission?

Authors:  Michele Bamgartner; Ihuoma Njoku; Jacelyn E P Lever; Ayushi Aggarwal; Monica Verduzco-Gutierrez
Journal:  Acad Emerg Med       Date:  2021-06-15       Impact factor: 5.221

3.  A 12-hospital prospective evaluation of a clinical decision support prognostic algorithm based on logistic regression as a form of machine learning to facilitate decision making for patients with suspected COVID-19.

Authors:  Monica I Lupei; Danni Li; Nicholas E Ingraham; Karyn D Baum; Bradley Benson; Michael Puskarich; David Milbrandt; Genevieve B Melton; Daren Scheppmann; Michael G Usher; Christopher J Tignanelli
Journal:  PLoS One       Date:  2022-01-05       Impact factor: 3.752

4.  A Machine Learning Model for Predicting Hospitalization in Patients with Respiratory Symptoms during the COVID-19 Pandemic.

Authors:  Victor Muniz De Freitas; Daniela Mendes Chiloff; Giulia Gabriella Bosso; Janaina Oliveira Pires Teixeira; Isabele Cristina de Godói Hernandes; Maira do Patrocínio Padilha; Giovanna Corrêa Moura; Luis Gustavo Modelli De Andrade; Frederico Mancuso; Francisco Estivallet Finamor; Aluísio Marçal de Barros Serodio; Jaquelina Sonoe Ota Arakaki; Marair Gracio Ferreira Sartori; Paulo Roberto Abrão Ferreira; Érika Bevilaqua Rangel
Journal:  J Clin Med       Date:  2022-08-05       Impact factor: 4.964

5.  The MedConnect Program: Symptomatology, Return Visits, and Hospitalization of COVID-19 Outpatients Following Discharge From the Emergency Department.

Authors:  Bryana L Bayly; Jacquelyn B Kercheval; James A Cranford; Taania Girgla; Arjun R Adapa; Ginette V Busschots; Katheen Y Li; Marcia Perry; Christopher M Fung; Colin F Greineder; Eve D Losman
Journal:  Cureus       Date:  2022-07-12

6.  'Doing the best we can': Registered Nurses' experiences and perceptions of patient safety in intensive care during COVID-19.

Authors:  Louise Caroline Stayt; Clair Merriman; Suzanne Bench; Ann M Price; Sarah Vollam; Helen Walthall; Nicki Credland; Karin Gerber; Vid Calovski
Journal:  J Adv Nurs       Date:  2022-08-20       Impact factor: 3.057

7.  Blood gene expression predicts intensive care unit admission in hospitalised patients with COVID-19.

Authors:  Rebekah Penrice-Randal; Xiaofeng Dong; Andrew George Shapanis; Aaron Gardner; Nicholas Harding; Jelmer Legebeke; Jenny Lord; Andres F Vallejo; Stephen Poole; Nathan J Brendish; Catherine Hartley; Anthony P Williams; Gabrielle Wheway; Marta E Polak; Fabio Strazzeri; James P R Schofield; Paul J Skipp; Julian A Hiscox; Tristan W Clark; Diana Baralle
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

8.  Outcomes for emergency department patients with suspected and confirmed COVID-19: An analysis of the Australian experience in 2020 (COVED-5).

Authors:  Gerard M O'Reilly; Rob D Mitchell; Biswadev Mitra; Hamed Akhlaghi; Viet Tran; Jeremy S Furyk; Paul Buntine; Anselm Wong; Vinay Gangathimmaiah; Jonathan Knott; Allison Moore; Jung Ro Ahn; Quillan Chan; Andrew Wang; Han Goh; Ashley Loughman; Nicole Lowry; Liam Hackett; Muhuntha Sri-Ganeshan; Nicole Chapman; Maximilian Raos; Michael P Noonan; De Villiers Smit; Peter A Cameron
Journal:  Emerg Med Australas       Date:  2021-08-13       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.